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Background: Carbon nanotubes (CNT) represent a great promise for technological and industrial development but
serious concerns on their health effects have also emerged. Rod-shaped CNT are, in fact, able to induce asbestos-like
pathogenicity in mice including granuloma formation in abdominal cavity and sub-pleural fibrosis. Exposure to CNT,
especially in the occupational context, happens mainly by inhalation. However, little is known about the possible effects
of CNT on pulmonary allergic diseases, such as asthma.
Methods: We exposed mice by inhalation to two types of multi-walled CNT, rigid rod-like and flexible tangled CNT, for
four hours a day once or on four consecutive days. Early events were monitored immediately and 24 hours after the
single inhalation exposure and the four day exposure mimicked an occupational work week. Mast cell deficient mice
were used to evaluate the role of mast cells in the occurring inflammation.
Results: Here we show that even a short-term inhalation of the rod-like CNT induces novel innate immunity-mediated
allergic-like airway inflammation in healthy mice. Marked eosinophilia was accompanied by mucus hypersecretion, AHR
and the expression of Th2-type cytokines. Exploration of the early events by transcriptomics analysis reveals that a
single 4-h exposure to rod-shaped CNT, but not to tangled CNT, causes a radical up-regulation of genes involved in
innate immunity and cytokine/chemokine pathways. Mast cells were found to partially regulate the inflammation
caused by rod-like CNT, but also alveaolar macrophages play an important role in the early stages.
Conclusions: These observations emphasize the diverse abilities of CNT to impact the immune system, and they
should be taken into account for hazard assessment.
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AsthmaBackground
Allergic asthma is a chronic inflammatory disorder of the
epithelial surfaces of the lung, characterized by airway
hyperresponsiveness (AHR), mucus overproduction, pul-
monary eosinophilia and allergen-driven T helper (Th) 2
lymphocyte polarization [1]. Coordinated production of
the Th2 cytokines IL-4, IL-5 and IL-13, and production
of allergen-specific IgE antibodies drives the allergic
inflammation through the recruitment and activation* Correspondence: harri.alenius@ttl.fi
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unless otherwise stated.of T-cells and eosinophils. Chronic Th2 inflammation
may finally lead to structural changes in the airways in
a process called airway remodeling [2]. Despite the
involvement of several cell types, Th2 cells are considered
to be pivotal in the pathobiology of asthma.
Asthma represents the most important chronic inflam-
matory disease of the lung and is the major childhood
illnesses in Europe and in US. The incidence of asthma is
steadily increasing in industrialized countries affecting
about 5–10% of the population [3,4]. The reason of
increased asthma prevalence is unknown but it has been
linked with improved hygienic standards. This has been
called the “hygiene hypothesis” arguing that early childhood
exposure to microbes inhibits the tendency to developl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hypothesis suggests that more exposure to a wide variety of
novel chemicals in the environment, in consumer products
and in occupational settings, is the major cause for the
sudden peak in asthma prevalence [6,7].
The unique properties of carbon nanomaterials and
their applications have the potential for a remarkable
technological and economic growth [8]. The ability to cus-
tom synthesize carbon nanotubes (CNT) with attached
functional groups has opened new avenues to design high
surface area catalyst supports and materials with high
photochemical and electrochemical activity [9]. CNT
are also among the strongest and stiffest materials yet
discovered in terms of tensile strength and elastic
modulus. However, the rod-like shape of certain types
of CNT has been compared to asbestos fibers, raising
concern that their widespread use may lead to serious
health consequences. It has been previously reported
that rigid rod-like CNT are able to induce asbestos like
pathogenicity when introduced as a single intraperitoneal
dose to mice, acting as a surrogate tissue for mesothelial
lining of the lung [10]. Moreover, subcutaneous [11],
intratracheal [12] and intranasal [11] administration of
multi-walled CNT have been shown to aggravate allergen-
induced airway inflammation and inhalation of high-dose
of the CNT has been found to reach the sub-pleural tissue
and induce sub-pleural fibrosis in OVA-sensitized mice
[13]. In the present study, we examined whether inhalation
exposure, mimicking real-life exposure scenarios, to rigid
rod-shaped CNT (rCNT) or to tangled CNT (tCNT) with-
out pre-sensitization to any allergens is able to induce
asthma-like pathologies.Results
Inhaled rCNT trigger eosinophilia in lungs
To study whether CNT have the ability to recruit eosin-
ophils in the airways, a distinctive sign of allergic airway
inflammation, mice were exposed to rCNT or tCNT
aerosol for 4 h/day for 4 consecutive days. rCNT caused
a decrease in the number of alveolar macrophages
in bronchoalveolar lavage fluid (BAL; Figure 1a) and
induced the recruitment of inflammatory cells, especially
eosinophils (Figure 1b), while no significant changes in
influx of these cell types in response to tCNT treatment
were found. Likewise, in the lung tissue, the presence of
eosinophils was seen after rCNT treatment, but not after
tCNT (Figure 1c-e). Moreover, rCNT fibers were detected
in alveolar macrophages in interstitial areas (Figure 1f )
and macrophages were found to undergo “frustrated
phagocytosis” and form foreign-body giant cells specif-
ically in response to rCNT (Figure 1g). These results
indicate that unlike inhaled tCNT, rCNT are able to
trigger eosinophilic inflammation in lungs.Inhalation of rCNT induces signs associated with allergic
airway inflammation
Classical signs of asthma include mucus hypersecretion,
AHR and expression of Th2 type cytokines. Since it is well
known that AHR cannot be elicited in the C57BL/6 mouse
strain [14], we used BALB/c mice to demonstrate that
rCNT inhalation induces AHR to inhaled metacholine
(Figure 2a; Cellular infiltration in BAL and cytokine/che-
mokine expression in the lung tissue of rCNT exposed
BALB/c mice is given in Additional file 1). We also found
that rCNT, but not tCNT, triggered significant activation of
mucin-producing goblet cells 24 h after 4-day inhal-
ation exposure in C57BL/6 mice (Figure 2b-e). In
addition, up-regulation of Th2 type cytokines Il-13 and Il-5
transcriptional levels (Figure 2f) and down-regulation of
Th1 cytokine Ifn-γ (Figure 2g) after exposure to rCNT were
evidenced in lung tissue. Furthermore, mRNA expression
of eosinophil-attracting chemokines Ccl11, Ccl24 and
Ccl17 was triggered by rCNT (Figure 2h). tCNT treatment
had no effect on the expression of Il-13, Ifn-γ and Ccl24,
however, it suppressed Il-5 and elevated Ccl11 and Ccl17
production. These results show that inhaled rCNT cause
AHR, mucus production and trigger production of Th2
type cytokines and eosinophil chemoattractants, and
thereby suggest that rCNT fibers can elicit a condition simi-
lar to allergic airway inflammation.
Mast cells partially regulate the development of
rCNT-triggered allergic-like airway inflammation
Mast cells are one of the main mediators in immediate
allergic reactions. To explore the involvement of this cell
type in rCNT-induced inflammation, mast cell deficient
KitW-sh mice were used. 24 h after 4-day inhalation ex-
posure to rCNT, significantly elevated number of eosino-
phils was found in KitW-sh as compared to wild type
(WT) C57BL/6 mice, however, no significant differences
were seen in the number of neutrophils (Figure 3a) and
lymphocytes (Additional file 2a). Mast cells were not
found to mediate the activation of goblet cells as the
number of periodic acid-Schiff (PAS)+ cells were
comparable between both strains after rCNT exposure
(Figure 3b). While rCNT-induced mRNA expression of
Il-13 was highly dependent on mast cells (Figure 3c),
production of Ccl11, Ccl24 and Ccl17 was not signifi-
cantly affected by these cells (Additional file 2b).
Transcriptome analysis of lung tissue reveals rapid
activation of innate immune system in response to
inhaled rCNT
We further investigated the early regulatory events at the
transcriptomic level (NCBI GEO Accession Number
GSE50176, Additional file 3). C57BL/6 mice were hence
exposed by inhalation to rCNT or tCNT once for 4 h, and
sacrificed either immediately or 24 h after the cessation of
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Figure 1 Inhaled rCNTs induce strong pulmonary eosinophilia in mice after exposure for 4 consecutive days. C57BL/6 mice were
exposed to rCNT or tCNT for 4 h/day for 4 consecutive days and the samples were collected 24 h after the last treatment. a,b: BAL cell counts
showed the ability of rCNT to cause a decrease in the number of alveolar macrophages (a) and induce recruitment of inflammatory cells,
especially eosinophils (b). c-e: H&E-stained lung sections of untreated (c), tCNT-treated (d) and a rCNT-treated (e) mouse exhibiting that eosinophilia
was specific to rCNT (e, see inset for eosinophils). f: internalized rCNT fibers in alveolar macrophages were detected in interstitial areas in Picrosirius
red-stained lung sections. g: an image of BAL cells showing a foreign-body giant cell containing rCNT, macrophages undergoing “frustrated phagocytosis”,
eosinophils and a neutrophil. Columns and error bars in a and b represent mean values ± standard error of mean (SEM; n = 9-20). Images c and d are
shown with a 100 μm scale bar, f-g and the inset is shown with a 25 μm scale bar. **P< 0.01; ***P< 0.001. C, untreated control group; HPF, high
power field.
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mild effect on the gene expression and these samples
tended to cluster together with the untreated ones
(Figure 4a). On the contrary, the effect of rCNT was
remarkable at the same time point, impacting many more
genes and with much greater amplitude of variation from
the baseline samples (Figure 4a,b). At 4 h, rCNT exposure
induced almost exclusively pathways essential for the
innate immunity (e.g. NOD-like receptor and Toll-like
receptor signaling pathways, Chemokine signaling path-
ways and Cytokine-cytokine receptor interaction path-
ways) (Figure 4c). Moreover, cancer related pathways as
well as insulin signaling pathways were up-regulated after
rCNT exposure. In sharp contrast, the innate immunitypathways were either not activated or were down-
regulated after a 4 h inhalation of tCNT (Figure 4c). At
24 h following the 4 h exposure, a stronger effect of tCNT
took place on a wider set of genes, causing changes similar
in size and range of variation to those elicited by rCNT.
Nonetheless, the gene expression signatures of rCNT and
tCNT were quite distinct, as the group of the genes with
similar behavior in both treatments was relatively small
(Figure 4b, Additional file 4). In addition, direct compari-
son of the transcriptome of rCNT and tCNT exposed
mice at each time point revealed that innate
immunity pathways and chemokine-cytokine signaling
pathways were significantly more expressed after
rCNT, whereas lysosomal activity and carbohydrate
Il-13 mRNA
C tCNT rCNT
0
2
4
6
8
10
12
***
***
Fo
ld
ch
an
ge
Ccl24 mRNA
C tCNT rCNT
0
2
4
6
***
***
F
o
ld
ch
an
g
e
Ccl17 mRNA
C tCNT rCNT
0
2
4
6
8
**
****
Fo
ld
ch
an
ge
Il-5 mRNA
C tCNT rCNT
0.0
0.5
1.0
1.5
2.0
2.5
*
*****
F
o
ld
ch
an
g
e
Ccl11 mRNA
C tCNT rCNT
0
1
2
3
*
**
F
o
ld
ch
an
g
e
Ifn- γ mRNA
C tCNT rCNT
0.0
0.5
1.0
1.5
**
**
F
o
ld
ch
a n
g
e
f
c d e
g
PAS+ cells
C tCNT rCNT
0
5
10
15
20
**
***
C
e
lls
/2
0
0
 μ
m
ba
AHR
0
50
100
150
200
C
rCNT
12.56.253.125
MCh (mg/ml)
P
en
h
*
h
Figure 2 (See legend on next page.)
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Figure 2 Inhalation to rCNT induces AHR, mucus secretion and induction of Th2 type cytokines in the lungs. a: BALB/c mice exposed to
rCNT for 4 h/day on 4 consecutive days showed enhanced AHR to metacholine on day 5. b-h: using the same exposure schedule, C57BL/6 mice were
exposed to tCNT or rCNT and sacrificed on the following day. b: PAS-stained lung sections were used to determine the numbers of mucin-producing
goblet cells. c-e: representative images of PAS-stained lung tissue of an untreated mouse (c) and mice exposed to tCNT (d) and rCNT (e) that show
markable activation of mucin-producing cells in lungs of rCNT-exposed but not in tCNT-exposed mice. f, g: the mRNA expression levels measured in
lung tissue revealed an upregulation of Th2 type cytokines Il-13 and Il-5 (f) and downregulation of Th1 cytokine Ifn-γ (g) after exposure to rCNT.
h: furthermore, mRNA expression of eosinophil-attracting chemokines Ccl11, Ccl24 and Ccl17 was triggered in lungs by rCNT. Results of AHR
measurements (a) are expressed as mean enhanced pause values (Penh) ± SEM (n = 9-11). PAS + cell counts (b) represent the average of
positive cells per 200 μm of bronchus surface counted from three bronchi per mouse in control group and six bronchi per mouse in
CNT-exposed groups (n = 10-20). Images c-e are shown at x400 magnification with a 50 μm scale bar. mRNA expression levels measured by qRT-PCR
are presented as fold changes compared to untreated control mice (n = 10-20). *P < 0.05; **P < 0.01; ***P < 0.001. MCh, metacoline; C, control group.
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(Additional file 5). Some highly significant genes in
the microarray analysis also relevant to asthma (Ccl2,
Ccl11, Ccl24 and Cxcl5) were further confirmed by
quantitative PCR (Additional file 6).a
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Figure 3 Mast cells play a partial role in the development of rCNT-trig
KitW-sh mice in C57BL/6 background were exposed to rCNT for 4 h/day on 4 c
that mast cells affect the migration of eosinophils but not neutrophils into th
mice indicating that mast cells do not regulate the activation of goblet cells.
significant down-regulation of Th2 type cytokine Il-13 in KitW-sh mice compared
per 200 μm of bronchus surface counted from three bronchi per mouse in con
mRNA expression levels in c are presented as fold changes relative to untreated
**P< 0.01; ***P< 0.001.Alveolar macrophages and mast cells play a role in the
initiation of the inflammatory and allergy-like rCNT-induced
responses
To investigate the involvement of macrophages in the
early stages of rCNT-triggered reactions, we exposedIl-13 mRNA
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Figure 4 Transcriptome analysis of lung tissue reveals rapid activation of innate immune system in response to inhaled rCNT.
a: heatmap of differentially expressed genes (linear FC > |1.5|, post hoc adjusted P-value = 0.01) in lungs of mice exposed to rCNT or tCNT for 4 h
and sacrificed either immediately after exposure or on the following day. Genes are arranged by hierarchical clustering analysis. Untreated (UT)
and tCNT-exposed lung samples share similar expression patterns shortly after 4-h exposure. Red color indicates higher expression while green
denotes lower expression. b: Venn diagram of the microarray results summarizing the numbers of differentially expressed genes (linear FC > |1.5|,
post hoc adjusted P-value = 0.01) in lung tissue after 4 h exposure to CNT. The diagram shows that rCNT cause a markable expression of multiple
distinct genes already after 4-h exposure (776 genes) while the number of genes specific to tCNT is notably lower (109 genes). c: pathway
bubble-plot shows that inhalation of rCNT activates several innate immunity-associated pathways after the 4 h exposure. The diameter of each
circle represents the number of genes annotated in each pathway (legend “count”). Red color indicates up-regulated pathways and green color
down-regulated pathways compared to untreated controls.
Rydman et al. Particle and Fibre Toxicology 2014, 11:48 Page 7 of 17
http://www.particleandfibretoxicology.com/content/11/1/48C57BL/6 mice for 4 h and collected BAL and lung
tissue samples immediately or 24 h after the expos-
ure. Since macrophages are the major cell type in
BAL at early stages of the inflammatory response, we
compared the mRNA expression of pro-inflammatory
and pro-allergic cytokines in BAL cells and lung tis-
sue (Figure 5a,b). We found that Il-1β and Tnf-α are
produced mainly by alveolar macrophages while Th2-
promoting cytokine Il-33, and eosinophil-attracting
chemokine Ccl17 are expressed in BAL cells as well
as in other cell types present in lung tissue. In
addition, we found that BAL macrophages express
Ccl2 and Ccl7, which may contribute to the stimula-
tion of monocyte recruitment to the site of inflamma-
tion (Additional file 7).
The role of mast cells was investigated in lung tis-
sue of C57BL/6 and KitW-sh mice exposed to rCNT
for 4 h and sacrificed on the following day. Results of
mRNA expression levels of Th2 type cytokines and
pro-allergic chemokines showed that Il-13 and Il-4
were derived from mast cells (Figure 5c) while ex-
pression of Il-33, Il-5, Ccl11, Ccl24 and Ccl17 was
not influenced by deficiency of these cells (Additional
file 8).
Discussion
Along with the increase in production and use of
CNT in numerous applications, also occupational
and environmental exposure to these materials has
increased. This has raised awareness of the potential
harmfulness of CNT on human health. One of the
main exposure routes associated with ENM is the
respiratory tract and hence most of the in vivo stud-
ies have concentrated on investigating pulmonary
effects.
Several studies have shown that CNT fibers have adju-
vant capacity as they aggravate allergen-induced airway
inflammation [11-13,15,16]. Here, we investigated
whether CNT have the ability to induce characteristics
similar to allergic airway inflammation in healthy mice.
Using different types of CNT, we exposed C57BL/6 mice
to an aerosol of rCNT or tCNT repeatedly for 4 h, for atotal of 4 days and collected samples 24 h after the last
treatment, thus mimicking a one-week occupational ex-
posure. Inhalation of rCNT elicited a drastic infiltration
of eosinophils but only a minor increase in neutrophils.
Pulmonary eosinophilia is a classical sign of allergic air-
way inflammation and asthma in which eosinophils are
critically involved in the induction of airway hyperreac-
tivity, elevated mucus production, airway remodeling
and asthma exacerbations [17,18]. In contrast, exposure
to tCNT did not cause morphologically evident lung in-
flammation. In a study by Park et al. neutrophilic
inflammation was induced one day after intratracheal
administration of multi-walled carbon nanotubes
(MWCNT) [19]. Similarly, Morimoto et al. reported
MWCNT-induced neutrophilia peaking at day 3 after
intratracheal instillation [20]. However, other studies
performed via pharyngeal aspiration have shown that
MWCNT induce an influx of both neutrophils and eo-
sinophils, [21] especially at lower doses [22]. Although
the inhalation method is the closest to real-life scenarios,
the number of such studies is very limited. In contrast to
our observations, a 3-month inhalation of MWCNT in-
duced mild neutrophilic, but not eosinophilic, pulmon-
ary inflammation in rats [23]. Similar phenomenon was
seen also in mice where the authors reported pulmonary
neutrophilia after a 2-day exposure [24]. Nonetheless,
assessing health effects of CNT in vivo is complex and
different results difficult to compare, due to varying
methods of exposure in different organisms as well as
the different physico-chemical properties of the tested
materials.
In the present study, the rCNT triggered cytopathology
included a substantial number of macrophages that
attempted to engulf CNT aggregates and a presence of
foreign body giant cells (FBGC). However, the FBGC did
not appear in mice after tCNT treatment. Macrophages
undergoing “frustrated phagocytosis” and formation of
FBGC in response to MWCNT have been reported earlier
after intraperitoneal injection using the same material as
in our study [10]. Mangum et al. [25] found carbon brid-
ges between macrophages after a single oropharyngeal
aspiration of SWCNT in rats. Giant cells arise from a
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Figure 5 (See legend on next page.)
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Figure 5 Alveolar macrophages and mast cells mediate the early inflammatory and pro-allergic responses induced by rCNT. a,b: BAL and
lung tissue were collected from C57BL/6 mice exposed to rCNT for 4 h and sacrificed either immediately or on the following day. Comparison of
mRNA expression levels of cytokines/chemokines in BAL cells (a) and lung tissue (b) showing that pro-inflammatory cytokines Il-1β and Tnf-α
are produced by alveolar macrophages which are the major cell type in BAL at early time points (data not shown) while Th2-promoting cytokine Il-33,
and eosinophil-attracting chemokine Ccl17 are expressed in BAL cells as well as in other cells types present in lung tissue. c: levels of Th2 type cytokines
Il-13 and Il-4 in lungs were dependent on the presence of mast cells as the expression of these cytokines was significantly lower in KitW-sh mice exposed
to rCNT for 4 h and sacrificed on the next day. mRNA expression levels in a and b are presented as fold changes relative to untreated
control mice (n = 5-8). In c, values indicate fold changes compared with control mice of the corresponding strain (n = 7-9). *P < 0.05; **P < 0.01;
***P < 0.001. C, untreated control group.
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[26]. These cells are recognized as the pathological hall-
mark of granulomatous diseases [26]. Although we did not
observe granulomas after the 4-day exposure, FBGC might
be an indication of their upcoming formation. Their forma-
tion has been induced by alternative activation of macro-
phages in vitro by stimulation of Th2 type cytokines Il-4
and Il-13 [27,28]. Alternatively activated macrophages have
been also associated with allergic airway inflammation [29].
Excessive mucus secretion in the airways and AHR are
classical features of allergic airway inflammation [2]. We
found that pulmonary eosinophilia caused by rCNT was
accompanied by increased goblet cell hyperplasia as well
as elevation of AHR to inhaled metacholine. Moreover,
the up-regulation of Th2 type cytokines Il-13 and Il-5,
and down-regulation of Th1 type cytokine Ifn-γ in the
lung tissue after rCNT inhalation supports the induction
of allergic-like airway inflammation. Th2 type cytokines
are typically found in the asthmatic airways [1] and the
decreased level of Ifn-γ is to be expected since Th1 type
cytokines are considered to be counter-regulatory to the
Th2 type cytokines. Finally, eosinophil-chemoattractants
were notably elevated, supporting the rCNT-induced
pulmonary eosinophilia. To our knowledge, no previous
studies exist describing an array of features characteristic
to allergic airway inflammation and asthma after bare inhal-
ation exposure to CNT, as seen in the present study. It
should be also noted that full-blown allergic-like inflamma-
tion was elicited just in 5 days and without the conventional
protein allergen or treatment with an artificial adjuvant
substances (e.g. aluminum hydroxide). The current para-
digm proposes that asthma is initiated by a sensitization
phase, during which contact with (protein) allergens alerts
the immune system, polarizes allergen-specific Th2 lym-
phocytes and induces secretion of allergen specific-IgE anti-
bodies [2]. In our experimental set up, the conventional
sensitization phase cannot be developed due to the very
short period of time and the lack of protein allergens, indi-
cating that polarization of Th2 lymphocytes and generation
of IgE antibodies is not possible. Thus, the rCNT-induced
allergic-like inflammation is likely caused by the activation
of the innate immune system, eliciting a novel type ofallergic-like airway inflammation in the occupational health
context.
The Reactive Airways Dysfunction Syndrome (RADS)
is an occupational asthma-like syndrome that develops
rapidly after a single exposure to high levels of irritating
fume, smoke, vapor or aerosol [30]. RADS differs from
traditional asthma especially due to its acute nature with
no latency period. Initial respiratory symptoms are
followed by asthma-like symptoms and airway hyperre-
sponsiveness. Irritant-induced asthma (IrIA) is also used
to describe an asthmatic syndrome that results from a
single or multiple high dose exposures to irritant prod-
ucts. Interestingly, both RADS and IrIA induce signifi-
cant upper airway symptoms, nonspecific inflammation,
neurogenic inflammation, primarily lymphocytic cellular
infiltrate, macrophage activation, mast cell degranulation
and epithelial desquamation [31-34]. The airway inflam-
mation observed in the present study seems to be some-
thing in between the classic asthma and IrIA. Even
though the inflammation lacks the sensitization phase
and protein allergens, it still possesses classical features
of allergic asthma such as Th2 cytokines, mucus produc-
tion and pulmonary eosinophilia. Rather than allergens,
the rCNT seem to act more like irritants in inducing a
fast and dramatic innate immunity mediated Th2-type
airway inflammation similar to allergic asthma.
Mast cells are known to be the central effectors in
immediate hypersensitivity reactions [35]. After en-
countering an allergen, IgE-sensitized mast cells release
a broad panel of bioactive mediators and Th2 type
cytokines (e.g. IL-4, IL-5, IL-13) in order to initiate and
promote airway inflammation, and to strongly induce
development of T cell responses [3,35,36]. Although
traditional protein allergen-sensitization was not used
in our experimental setting, we were interested in ex-
ploring whether the mast cells would also mediate the
rCNT-driven inflammation. We found that the influx
of eosinophils was increased and the expression of Il-13
was significantly decreased in the lungs of the mast cell
deficient mice. However, the goblet cell activation was not
dependent on these cells and the eosinophil attracting
chemokines were likely derived from other sources. These
Rydman et al. Particle and Fibre Toxicology 2014, 11:48 Page 10 of 17
http://www.particleandfibretoxicology.com/content/11/1/48findings suggest that mast cells modulate the rCNT-
induced pulmonary inflammation partially.
Early events in the CNT-induced airway inflammation
were examined by transcriptomics profiling. The analysis
revealed that shortly after the 4 h exposure, the tissue of
untreated and tCNT-exposed mice shared similar ex-
pression patterns, which were drastically distinct from
rCNT-treated mice. Moreover, only rCNT induced in-
creased expression of a number of inflammation-
associated pathways. Since the transcriptomics data
suggested that rCNT activate several innate immunity
pathways, we wanted to estimate the role of alveolar
macrophages and lung tissue cells in these early events.
BAL cells were isolated immediately after and 24 h fol-
lowing the 4 h rCNT exposure and mRNA expression
levels of BAL cells were compared to the mRNA levels
of lung tissue of the same animals. Most of the pro-
inflammatory Il-1β and Tnf-α expression was likely
derived from the rCNT activated alveolar macrophages
(i.e. BAL cells) as the tissue expression levels were
much lower. On the other hand, the pro-allergic Il-33
[37], which promotes the activation of mast cells [38] and
alternative activation of macrophages, was expressed by
alveolar macrophages but also by other resident tissue
cells. Similarly, the pro-allergic chemokine Ccl17 [39],
whose overexpression has been observed earlier in lung
macrophages of asthmatic patients [40], was highly up-
regulated in BAL macrophages and lung tissue. Taken
together, the present results demonstrate that rCNT acti-
vated alveolar macrophages are an important source of
not only proinflammatory cytokines but also allergy pro-
moting cytokines and chemokines. To our knowledge the
transcriptomics analysis is a rather rarely used approach
in similar studies and the early events in the CNT exposed
mice appear weakly documented.
No significant induction of Il-13 and Il-4 was ob-
served from the isolated BAL cells (data not shown)
after a 4 h exposure to rCNT, suggesting that the alveo-
lar macrophages are not synthetizing these Th2 cyto-
kines at the early stages. Since mast cells are an
important source of Th2 type cytokines, [35] we inves-
tigated their potential role as an early source of these
cytokines. By using mast cell deficient mice we showed
that the expression of Th2 type cytokines Il-13 and Il-4
is significantly decreased in the absence of mast cells
suggesting that mast cells are likely an early source of
these Th2 cytokines in rCNT induced inflammation.
This is also supported by Katwa et al. [41] that report
MWCNT aspiration which actuates the extracellular
release of Il-33 in lung tissue, leading to the activation
of mast cells through the ST2 receptor and causing
adverse pulmonary and cardiovascular responses. It has
been previously reported that MWCNT induced Il-33
secretion from airway epithelia activating innate lymphoidcells and their release of Il-13 and Il-5 [21]. In order to
evaluate the possible role of innate lymphoid cells in the
present study we measured innate lymphoid cell 2 (ILC2)
markers Il-25 and ROR-α [42] in both BAL cells and lung
tissue, but found no up-regulation in their expression in
response to rCNT treatment (data not shown). Therefore,
we suggest that the early events of MWCNT-induced re-
sponses include the activation of mast cells by Il-33 de-
rived from macrophages or non-immune lung cells [41].
However we cannot completely exclude the role of ILC2
as their functions and markers are to date not completely
clear [43]. It is of interest that carbon materials, in this
case carboxy-fullerenes, can also act as inhibitors of aller-
gic reactions by affecting the mast cell function [44].
In summary, we demonstrate that inhalation of rigid
rod-shaped CNT induces all the signs of allergic airway
inflammation. Experiments with mast cell deficient mice
demonstrated that mast cells mediate the rCNT induced
pulmonary eosinophilia and the expression of Il-13. Ex-
ploration of the early events by transcriptomics analysis
reveals that a 4 h exposure to rCNT causes dramatic up-
regulation of genes involved in innate immunity and
cytokine/chemokine pathways, which also explains the
pulmonary inflammation seen after one-week exposure.
Early pro-inflammatory cytokines as well as pro-allergic
cytokines and chemokines are synthetized by rCNT-
activated alveolar macrophages, while mast cells are
likely an early source of rCNT induced Il-4 and Il-13.
Our results indicate that in addition to the previously
described asbestos associated pathologies, inhalation of
rod-like CNT is able to induce a novel innate immunity
mediated allergic-like airway inflammation-like reaction.
They also highlight marked dissimilarities in the ability
of different CNT to impact health. These observations
should be taken into account in the risk assessment as
well as in safety and protection measures when exposure
to CNT is possible. However more knowledge on the
long term effects, clinical impacts and dose–response
relationships is still needed to draw solid conclusions on
the risks of CNT.
Methods
CNT and their characterization
The types of MWCNT used in the study included a
sample of rod-like MWCNT (rCNT; Mitsui & Co., Ltd.,
Tokyo, Japan) that had straight, inflexible and rigid
fibers, and a sample of tangled MWCNT (tCNT; Cheap
Tubes, Inc., Brattleboro, VT, USA) which consisted of
curved fibers. The morphology of the CNT was charac-
terized by electron microscopy (Zeiss ULTRAPlus FEG-
SEM, Carl Zeiss NTS GmbH, Oberkochen, Germany;
Jeol JEM 2010 TEM, Jeol Ltd., Tokyo, Japan) and their
composition was analyzed by X-ray energy dispersive
spectroscope (EDS ThermoNoran Vantage, Thermo
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2010 TEM. Elemental composition data were expressed
as the average of three separate analyses. Physico-
chemical characteristics of the materials are shown in
Figure 6.tCN
Product name MWNTs 8-1
Manufacturer Cheap Tu
Properties provided by the 
producera
OD 8-1
Length 10
Purity 99.7
SSA >23
Morphology by SEM 
(Measure bar 200nm)b
Morphology by TEM 
(Measure bar 20nm)b
Composition by TEM-EDSc
Elements: C, resid
and Fe content in
Figure 6 Table of characteristics of the used multi-walled carbon nan
as provided by the vendor. bMorphology of the materials is pictured by electron
of three separate analyses. CNT, carbon nanotubes; EDS, energy dispersive X-ray
SSA, specific surface area; TEM, transmission electron microscopy; wt%, weight pAssessment of bacterial lipopolysaccharide content
Levels of biologically active endotoxin in MWCNT were
measured using a kinetic chromogenic Limulus amebo-
cyte lysate assay (Kinetic QCL, Lonza, Walkersville, MD,
USA) according to the instructions provided by theT rCNT
5 nm OD XNRI MWNT-7
bes Inc. Mitsui & Co., Ltd.
5 nm
-50 µm
6 wt%
3 m2/g
OD >50nm 
Length ~13µm
Purity 99.79 wt%
SSA 26 m2/g
ual metal of Ni 
 total <1 wt%
Elements: C, residue content below 
the detection limit 0.1 wt%
otubes. aSize, purity and specific surface area are reported in the table,
microscopy (SEM and TEM). cElemental composition shown is the average
spectroscopy; OD, outside diameter; SEM, scanning electron microscopy;
ercent.
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were <0,022 EU/mg.Animals
Female C57BL/6, BALB/c and KitW-sh/HNihrJaeBsmJ
mice (7–8 weeks old) were purchased from Scanbur AB
(Sollentuna, Sweden) and quarantined for one week. Mice
were housed in groups of four in stainless steel cages
bedded with aspen chip and were provided with standard
mouse chow diet (Altromin no. 1314 FORTI, Altromin
Spezialfutter GmbH & Co., Germany) and tap water ad
libitum when not in exposure chamber. The environment
of the animal room was carefully controlled, with a 12-h
dark/light cycle, temperature of 20–21°C, and relative
humidity of 40–45%. The experiments were performed
in agreement with the European Convention for the
Protection of Vertebrate Animals Used for Experimental
and Other Scientific Purposes (Strasbourg March 18, 1986,
adopted in Finland May 31, 1990). The study was approved
by the Animal Experiment Board and the State Provincial
Office of Southern Finland.Aerosol generation
MWCNT were aerosolized with a fluidized bed aerosol
generator (FBAG; TSI Model 3400A [45]) for which the
materials were used without any pre-treatment. In the
generator, a chain transports CNT to the fluidizing bed
where material agglomerates are mechanically broken by
200-μm bronze pellets and continuous air flow. To in-
crease CNT feed to fluidizing bed, additional air flow
was used. Since the density of CNT was very low, the
material reservoir of the FBAG was not large enough to
accommodate material for a whole 4-h exposure. Thus,
the reservoir was filled after two hours from the begin-
ning of each exposure. During the experiments, the
pressure of the exposure chamber differed from the
atmospheric pressure ±200 Pa. Pressure in the chamber
was dependent on the experiment flow values and on
the air intake, whether it was drawn from room trough
HEPA filter or from the generator. Detailed scheme of
the inhalation setup is provided in Additional file 9.Particle characterization
Aerosol concentrations were measured with an optical
particle sizer (OPS, Grimm Dust Monitor 1.109). We used
the instrument calibration refractive index and particle
density of 2.6 g/cm3. In the Figure 7, the particle size is
expressed in relative units and the concentration is shown
in normalized units. Gravimetric samples were collected
onto nitrocellulose filter (Millipore) and weighted on an
analytical scale (RADWAG XA 110/Y; RADWAG Wagi
Elektroniczne, Radom, Poland).Experimental design
Mice were exposed to aerosolized rCNT or tCNT for
4 hours at a time once or on four consecutive days in a
whole-body inhalation chamber. Aerosol mass concentra-
tions used for individual experiments were within a range
of 6.2-8.2 mg/m3 for rCNT and 17.5-18.5 mg/m3 for tCNT.
There is still limited amount of information about the
concentrations found on workplaces partly due to the chal-
lenge of measuring the amounts of airborne CNT. In stud-
ies by Erdely et al. and Dahm et al. [46,47] levels of CNT
were found ranging from non-detectable to 1094 μg/m3.
During CNT synthesis in general, concentrations are most
likely in order of micrograms/m3 or less, but it is likely that
exposure concentrations to large CNT granulates may be
high (e.g. milligrams/m3) during post-processing of CNT
powders. During the experiments, untreated control mice
were housed in the same room with CNT-exposed animals.
All mice were sacrificed by isoflurane overdose either
immediately or 24 h after the exposure(s).
Measurement of airway responsiveness
Airway responsiveness of BALB/c mice was measured on
day 5 using a single chamber, whole-body plethysmograph
system (Buxco, Troy, NY, USA) as described earlier [48].
Lung reactivity parameters were expressed as enhanced
pause values (Penh). After measurement of lung respon-
siveness, mice were sacrificed using an overdose of isoflur-
ane and samples were collected for analyses.
Sample collection
The tracheas of mice were surgically exposed and can-
nulated with a blunt syringe for collecting the BAL. The
lungs were lavaged with 800 μl of Dulbecco’s phosphate
buffered saline (DPBS, Thermo Fisher Scientific Inc.,
Waltham, MA, USA) for 10 s. BAL sample was cytocen-
trifuged onto a slide, and the cells were stained with
May Grünwald-Giemsa (MGG) stain. The remaining cell
suspension was centrifuged, supernatant was removed
and the cells were fixed in 1:1 ethanol-DPBS mixture.
The thoraxes were then opened, and half of the left
pulmonary lobe was removed, quick-frozen and stored
at −70°C for RNA isolation. The rest of the lung tissue
was formalin-fixed, embedded in paraffin, cut, affixed on
slides, and stained with hematoxylin and eosin (H&E),
PAS and picrosirius red (PSR) solutions.
BAL cell counts
MGG-stained BAL cells were counted from three high-
power fields under light microscope (Leica DM 4000B;
Leica, Wetzlar, Germany).
Histology
Recruitment of inflammatory cells into the lungs and
morphological alterations of the tissue were assessed
Figure 7 (See legend on next page.)
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Figure 7 Concentrations and size distributions of CNT aerosols. a-d: normalized particle size distributions for rCNT experiments with the
average concentration of 8.2 mg/m3 (a) and 8.4 mg/m3 (b). Control material (tCNT), with the average particle concentration of 17.5 mg/m3 (c)
and 18.5 mg/m3 (d), was used to confirm that rCNT induced inflammatory reaction are truly rCNT-specific and biologically relevant. Parameters
of individual log-normal fits: Dp, the mean diameter in relative units; f, the distribution frequency; σ, the geometric standard deviation. e,f: Particle
concentration time series of two representative rCNT (e) and tCNT (f) experiments. Increase of the concentrations at 120 min is due to refilling of
the FBAG reservoir. Bold lines represent means of four 4 h exposures performed on 4 consecutive days and colored areas present standard
deviation (SD). In f, the red line represents a single 4 h experiment and hence SD is not shown.
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solution were used to evaluate formation of fibrosis
but also distribution of CNT within lungs since black
fibers were easily detectable on the light background
(Figure 1e). The number of mucus-producing cells was
determined after PAS-staining from three bronchi per
mouse in control group and six bronchi per mouse in
treatment groups by counting PAS+ cells from 200 μm
of bronchus surface under light microscope.
mRNA expression of cytokines and chemokines in lungs
tissue
Lung samples were placed into Lysing matrix D tubes
(MP Biomedicals, Illkirch, France) containing 1 ml of
TRIsure reagent (Bioline Reagents Ltd., London, UK) and
homogenized in a FastPrep FP120 machine (BIO 101,
Thermo Savant, Waltham, MA, USA). The RNA extraction
was performed following instructions provided by Bioline
Reagents. The quantity and purity of isolated RNA was
determined by NanoDrop spectrophotometer (ND-1000,
Thermo Fisher Scientific Inc., Wilmington, NC, USA).
Complementary DNA (cDNA) was synthesized from
500 ng of total RNA in a 25 μl reaction using MultiScribe
Reverse Transcriptase and random primers (The High-
Capacity cDNA Archive Kit, Applied Biosystems, Foster
City, CA, USA) according to the manufacturer’s protocol.
The synthesis was performed in a 2720 Thermal Cycler
(Applied Biosystems, Carlsbad, CA, USA) starting at 25°C
for 10 minutes and continuing at 37°C for 120 minutes.
Primers and probes (18S ribosomal RNA, Ccl2, Ccl7,
Ccl11, Ccl17, Ccl24, Cxcl5, Ifn-γ, Il-1β, Il-5, Il-13, Il-33,
Tnf-α) for real-time quantitative polymerase chain reaction
(PCR) analysis were ordered as pre-developed assay re-
agents from Applied Biosystems. The PCR assays were per-
formed in 96-well optical reaction plates with Relative
Quantification 7500 Fast System (7500 Fast Real-Time PCR
system, Applied Biosystems) by the manufacturer’s instruc-
tions. Amplifications were done in 11 μl reaction volume
containing TaqMan universal PCR master mix and primers
provided by Applied Biosystems and 1 μl of cDNA sample.
Ribosomal 18S was used as an endogenous control.
DNA microarrays
The microarray data have been deposited in NCBI
Gene Expression Omnibus (GEO) database [49] and areaccessible through GEO Series accession number
GSE50176 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE50176). Total RNA samples isolated from
lung tissue as described above were quantified by
NanoDrop and the quality was verified by Agilent
Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA, USA). Independent pools of two RNA samples each
(total of 600 ng) were labeled using T7 RNA polymerase
amplification method (Low Input Quick Amp Labeling
Kit, Agilent Technologies), according to the instructions
of the manufacturer. cRNAs were then labeled with Cy3
and Cy5 dyes (Agilent Technologies) and hybridized to
the Agilent 2-color 60-mer oligo arrays (Agilent SurePrint
G3 Mouse GE 8x60K). The slides were washed and
scanned with Agilent Microarray Scanner G2505C (Agilent
Technologies) and the raw intensity values were obtained
with the Feature Extraction software, version 11.0.1.1
(Agilent Technologies). Raw data was quality checked ac-
cording to the Agilent standard procedures. The median
foreground intensities were imported into the R software
version 3.0.0 (http://cran.r-project.org) [50] and analyzed
with the BioConductor package limma [51]. Log2 trans-
formation and quantile normalization was performed on
the single channel data separately, similarly for instance to
[52-54] and according to the suggestions by Smyth and
Altman [55]. Background correction was not carried out,
as suggested by Zahurak et al. [56]. Subsequently the batch
effect derived from the labeling was removed using the
ComBat method [57] implemented in the sva package
[58,59]. The values of the probes recognizing the same
NCBI Entrez Gene Ids [60] were further averaged into the
final expression matrix. Differentially expressed genes were
identified by using linear models and empirical Bayes pair-
wise comparisons (post hoc adjusted P < 0.01 and linear
FC > |1.5|) [61]. The resulting gene sets after Benjamini
and Hochberg post hoc correction [57] were considered to
be significant and were further studied by the DAVID ver-
sion 6.7 annotation tool [62] with the default parameters.
Statistical analysis of cell counts, mRNA levels and AHR
Graphs were constructed and data were analyzed using
GraphPad Prism 5 Software (GraphPad Software Inc., San
Diego, CA, USA). For all statistical analysis we first
performed analysis of variance using one-way ANOVA and
when the ANOVA was positive we performed post-testing.
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compare the differences between the groups. A P-value
of <0.05 was considered to be statistically significant.Additional files
Additional file 1: Cellular infiltration in BAL and cytokine/
chemokine expression in the lung tissue of rCNT exposed BALB/c
mice. BALB/c mice were exposed to rCNT for 4 h/day on 4 consecutive
days and sacrificed on day 5 after BUXCO-measurements. The figure
shows (a) cellular infiltration in BAL and (b) proinflammatory cytokine
Tnf-α and Il-6 expression in the lung tissue. (c) Th2 cytokine Il-13 and
chemokines Ccl11, Ccl17 expression. As can be seen from the figure, in
addition to AHR, there are also other strain-specific differences between
C57BL/6 and BALB/c described in more detail by e.g. Gueders MM. et al.
[63] and Watanabe H. et al. [64]. mRNA expression levels in b-c are
presented as fold changes relative to untreated control mice (n = 5-8).
***P < 0.001. C, untreated control group; HPF, high power field; rCNT,
rod-like multi-walled carbon nanotubes.
Additional file 2: Recruitment of lymphocytes and expression of
eosinophil-chemoattractants is not regulated by mast cells. Wild
type (WT) C57BL/6 mice and mast cell deficient KitW-sh mice were
exposed to rCNT for 4 h/day on 4 consecutive days and were sacrificed
on the following day. a: the number of lymphocytes in BAL. b: mRNA
expression levels of eosinophil-attracting chemokines Ccl11, Ccl24 and
Ccl17 in lung tissue measured by qRT-PCR. The values indicate fold
changes compared with control mice of the corresponding strain
(n = 7-9). *P < 0.05; **P < 0.01; ***P < 0.001. rCNT, rod-like multi-walled
carbon nanotubes.
Additional file 3: Tables of lists of the differentially expressed
genes from the microarray experiment. The tables with the
differentially expressed genes in each of the relevant pairwise
comparisons are reported in each sheet of the Microsoft Excel archive,
named accordingly. In each table, the significantly differentially expressed
genes (Benjamini and Hochberg post hoc corrected p-value < 0.01 and
absolute log2 fold change > 0.58) are ordered according to the decreasing
log2 fold change. The NCBI Entrez Gene IDs, gene info and gene symbols
are shown. Additionally, for each significant gene, the average expression
across the microarray samples, the t-test value, the nominal p-value, the
adjusted p-value and the B value are also reported.
Additional file 4: rCNT exposure causes changes in the number of
significant genes at the early stage after exposure. a: column chart
representing the number of up and down regulated genes after 4 h
exposure, either sacrificed immediately or the following day. The number
of differentially expressed, significant genes (Fold Change > |1.5|, post-hoc
adjustedP-0.01) is highest with rCNT after 4 h (>3000 genes). The amount
is already decreasing after 24 h, while the number of expressed genes is
on the contrary increasing by time (4 h→ 24 h) when exposed to tCNT.
b: heatmap indicating the different expression patterns between the
rod-like and tangled CNT at 4 h time point, denoting the clear difference
between the gene expression patterns after exposure. c: same pattern can
be observed on a heatmap showing the differentially expressed genes after
4 h exposure when sacrificed on the following day, separating clearly the
rCNT and tCNT from each other. rCNT, rod-like multi-walled carbon
nanotubes; tCNT, tangled multi-walled carbon nanotubes.
Additional file 5: Direct comparison of the transcriptome of rCNT
and tCNT exposed mice. Pathway bubble plot revealed that innate
immunity pathways and chemokine-cytokine signaling pathways were
significantly more expressed after exposure to rCNT, whereas lysosomal
activity and carbohydrate metabolism pathways were induced by exposure
to tCNT. The diameter of each circle represents the number of genes
annotated in each pathway (legend “count”). Blue color refers to
tCNT-induced pathways and brown color to rCNT-induced pathways.
rCNT, rod-like multi-walled carbon nanotubes; tCNT, tangled
multi-walled carbon nanotubes.
Additional file 6: qRT-PCR validation of mRNA microarray results.
On the basis of the mRNA microarray results, four genes were selectedfor validation by qRT-PCR taking into account their biological relevance
for allergic asthma. The microarray measurements were considered valid
if the expression was concordant with microarray and qRT-PCR p-value
was <0,05. qRT-PCR results confirmed significant upregulation of
eosinophil-attracting chemokines Ccl11 and Ccl24, monocyte-recruiting
chemokine Ccl2 and neutrophil-chemoattractant Cxcl5 in lungs of
rCNT-treated mice compared with tCNT-exposed mice at both time
points. mRNA expression levels are presented as fold changes relative to
untreated control mice (n = 4-8). *P < 0.05; **P < 0.01; ***P < 0.001. C,
untreated control group. rCNT, rod-like multi-walled carbon nanotubes;
tCNT, tangled multi-walled carbon nanotubes.
Additional file 7: During the early stages of inflammation, rCNT
stimulate the expression of RIG-I-regulated chemokines Ccl2 and
Ccl7 in alveolar macrophages. a, b: C57BL/6 mice were exposed to
rCNT for 4 h and sacrificed either immediately or on the following day.
RIG-I-regulated chemokines Ccl2 and Ccl7 were significantly expressed at
the RNA level in BAL cells (a) and in lung tissue (b) already after 4-h
exposure and the expression levels rose even higher by the following
day. These data indicate that alveolar macrophages as well as resident
lung cells are early source of these chemokines. mRNA expression levels
are presented as fold changes compared to untreated control mice
(n = 8). *P < 0.05; **P < 0.01; ***P < 0.001. rCNT, rod-like multi-walled
carbon nanotubes.
Additional file 8: In the early phase of inflammation, mast cells are
not the only cell type leading to T helper (Th2) differentiation and
eosinophil recruitment in lungs. Mast cell deficient KitW-sh mice and
their wild type (WT) C57BL/6 control mice and were exposed to rCNT for
4 h and were sacrificed on the following day. a: expression of Il-33 and Il-5
cytokines at the mRNA level in the lungs of rod-like CNT (rCNT)-exposed
mice did not differ significantly in KitW-sh mice compared with WT mice.
b: similarly, mRNA expression of Ccl11, Ccl24 and Ccl17 was not dependent
on the presence of mast cells. The values represent fold changes
compared with control mice of the corresponding strain (n = 7-9). **P< 0.01;
***P< 0.001. rCNT, rod-like multi-walled carbon nanotubes.
Additional file 9: Scheme of the inhalation system for exposing
mice to carbon nanotubes with essential parameters and typical
flow values. In the fluidized bed aerosol generator (FBAG), CNTs are
transported to the fluidizing bed with a chain where bronze pellets
together with air flow (QBF) mechanically break material agglomerates.
CNT feed to fluidizing bed is enhanced with additional air flow (QT).
Thereafter, aerosolized CNT are directed to whole-body inhalation
exposure camber.
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